| |
| |
|
| Insider
Information: |
Sullivan Lara |
| Relationship: |
President and CEO, Dir... |
| City: |
Rockville |
| State: |
MD |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
2,403,882 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$0 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
2,403,882 |
|
|
| Total
Value |
$0 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
|
|
| Stock
price went down : |
|
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ocuphire Pharma, Inc |
OCUP |
|
|
0 |
|
0 |
Premium* |
|
|
Pyxis Oncology, Inc. |
PYXS |
President and CEO, Dir... |
2023-09-18 |
2,403,882 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
11 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PYXS |
Pyxis Oncology, Inc. |
President and CEO |
• • – |
2023-09-18 |
4 |
S |
$2.10 |
$17,936 |
D/D |
(8,541) |
2,403,882 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
President and CEO |
• • – |
2023-09-14 |
4 |
S |
$2.25 |
$225 |
D/D |
(100) |
2,412,423 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
President and CEO |
• • – |
2023-09-13 |
4 |
D |
$2.13 |
$393,500 |
D/D |
(184,742) |
2,412,523 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
President and CEO |
• • – |
2023-09-13 |
4 |
S |
$2.27 |
$6,816 |
D/D |
(3,000) |
2,597,265 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
President and CEO |
• • – |
2023-09-12 |
4 |
S |
$2.25 |
$11,071 |
D/D |
(4,917) |
2,600,265 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
President and CEO |
• • – |
2023-09-11 |
4 |
S |
$2.27 |
$45,414 |
D/D |
(20,000) |
2,605,182 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
President and CEO |
• • – |
2023-09-07 |
4 |
A |
$0.00 |
$0 |
D/D |
469,483 |
2,625,182 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
President and CEO |
• • – |
2023-03-24 |
4 |
A |
$0.00 |
$0 |
D/D |
703,379 |
2,155,699 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
Chief Executive Officer |
• • – |
2023-01-03 |
4 |
A |
$0.00 |
$0 |
D/D |
95,684 |
1,452,320 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
Chief Executive Officer |
• • – |
2022-03-31 |
4 |
A |
$0.00 |
$0 |
D/D |
742,574 |
1,041,363 |
0 |
- |
|
| PYXS |
Pyxis Oncology, Inc. |
Chief Executive Officer |
• • – |
2021-10-07 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
298,789 |
|
- |
|
11 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
